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The pathogenicity of feline infectious peritonitis virus (FIPV) is known to depend on macrophage tropism, and this macrophage infection is
enhanced by mediation via anti-S antibody (antibody-dependent enhancement, ADE). In this study, we found that TNF-alpha production was
increased with viral replication in macrophages inoculated with a mixture of FIPV and anti-S antibody, and demonstrated that this culture
supernatant had feline PBMC apoptosis-inducing activity. We also demonstrated that the expression level of the FIPV virus receptor, feline
aminopeptidase N (fAPN), was increased in macrophages of FIP cats. For upregulation of TNF-alpha and fAPN in macrophages, viral replication in
macrophages is necessary, and their expressions were increased by ADE of FIPV infection. It was demonstrated that a heat-resistant fAPN-inducing
factor was present in the culture supernatant of FIPV-infected macrophages, and this factor was TNF-alpha: fAPN expression was upregulated in
recombinant feline TNF-alpha-treated macrophages, and FIPV infectivity was increased in these macrophages. These findings suggested that FIPV
replication in macrophages increases TNF-alpha production in macrophages, and the produced TNF-alpha acts and upregulates fAPN expression,
increasing FIPV sensitivity.
© 2007 Elsevier Inc. All rights reserved.Keywords: FIP; ADE; TNF-alpha; fAPNIntroduction
Feline coronavirus (FCoV) is a coronavirus belonging to
Group 1 of the family Coronaviridae. FCoV is mainly composed
of nucleocapsid (N) protein, transmembrane (M) protein, and
peplomer spike (S) protein (Olsen, 1993). FCoVis classified into
types I and II according to the amino acid sequence of its spike
protein (Hohdatsu et al., 1991a; Motokawa et al., 1995, 1996).
Each of these types consists of two viruses: FIP-causing FIP
virus (FIPV) and non-FIP-causing feline enteric coronavirus
(FECV). FIPV and FECV of the same type cannot be dis-
tinguished by their antigenicity or at the gene level, and differ
only in their pathogenicity for cats. Thus, there are types I and II
FECV and FIPV in FCoV. FECV is asymptomatic in cats, but
FIPVinfection induces feline infectious peritonitis (FIP). FIP is a⁎ Corresponding author. Fax: +81 176 23 8703.
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doi:10.1016/j.virol.2007.02.006fatal disease mainly developing immune complex vasculitis ac-
companied by necrosis and pyogenic granulomatous inflamma-
tion. The difference in pathogenicity between FECVand FIPV is
considered to be associated with macrophage tropism of each
virus (Rottier et al., 2005).
When anti-FCoV antibody-positive cats are inoculated with
FIPV, the onset time of FIP is earlier than that in antibody-
negative cats, and symptoms are severer (Pedersen and Boyle,
1980). These phenomena are known as antibody-dependent en-
hancement (ADE) of infection. There have been several reports
concerning ADE of other virus infections (dengue virus, HIV
and respiratory syncytial virus, etc.; Suhrbier and La Linn, 2003;
Sullivan, 2001; Tirado and Yoon, 2003), and ADE of SARS-
CoV infection, belonging to coronavirus as FIPV, has recently
been reported (Weingartl et al., 2004; Yang et al., 2005). ADE of
FIPV infection has been reported to be induced by antibodies
against FIPV spike (S) protein (Hohdatsu et al., 1991b; Corapi
et al., 1992; Olsen et al., 1992). FIPV infects macrophages via
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on the macrophage surface, inducing ADE. ADE-induced
aggravation of the pathology in FIP cats is considered to be
due to an increased viral infection rate in macrophages.
Various studies concerning the FIP pathology have been per-
formed, including studies involving cytokine measurement in
FIP cats. Increases in the IL-1, IL-6, IL-10, and TNF-alpha levels
in FIP cats have been confirmed (Goitsuka et al., 1990, 1991;
Dean et al., 2003; Takano et al., 2007). Of these cytokines, TNF-
alpha is a feline lymphocyte apoptosis-inducing factor, and its
involvement in lymphopenia in FIP cats has been suggested
(Dean et al., 2003; Takano et al., 2007). Increased TNF-alpha
expression in monocytes and macrophages in FIP cats has been
noted (Dean et al., 2003; Kipar et al., 2005; Takano et al., 2007).
Kiss et al. (2004) reported that the expression level of TNF-alpha
mRNA in FIP cat-derived PBMCwas increased, whereas that of
IFN-gammamRNAwas reduced. However, many points remain
unclear, such as whether this increase in TNF-alpha is directly
related to FIPV replication in macrophages, and whether induc-
tion of ADE of FIPV infection in macrophages affects TNF-
alpha production.
Coronavirus belonging to Group 1 of the family Coronavir-
idae utilizes aminopeptidase N (APN) or angiotensin-converting
enzyme 2 (ACE2) as its virus receptor (Delmas et al., 1992;
Hohmann et al., 2005; Yeager et al., 1992; Tresnan et al., 1996).
APN is widely distributed in respiratory and digestive epithelial
cells and blood cells. In FCoV, type II FECV and FIPV are
known to utilize feline APN (fAPN) as their virus receptors
(Hohdatsu et al., 1998).Fig. 1. Relationship between FIP infection and TNF-alpha production in feline macro
alone, FIPV, FIPV+α-FIPV S MAb, and α-FIPV MAb alone for 3 days, and the cells
was measured by plaque assay (A, left), and TNF-alpha production was measured us
FCoV N gene (B, left) and TNF-alpha mRNA (B, right) in the cells were detected by R
in terms of the relative density value to the mRNA for the housekeeping gene GAPIn this study, we discovered that the expression levels of
TNF-alpha mRNA as well as fAPN mRNA were increased in
alveolar macrophages collected form FIP cats compared to those
from specific pathogen-free (SPF) cats. Thus, we investigated
how these increases in TNF-alpha and fAPN expressions in
macrophages were related to FIPV infection in vitro using
macrophages derived from SPF cats. We also investigated
whether these increases in TNF-alpha and fAPN expressions
were affected by ADE on FIPV infection in macrophages.
Results
FIPV infection and TNF-alpha production in feline alveolar
macrophages
To investigate the relationship between FIPV infection and
TNF-alpha production in feline alveolar macrophages, SPF cat-
derived alveolar macrophages were inoculated with FIPValone
and a mixture of FIPV and monoclonal antibody (MAb) 6-4-2.
After 3 days, the culture supernatant and cells were collected,
and FIPV replication and TNF-alpha production were measured.
The virus titer in the macrophage culture supernatant was
measured by plaque assay. TNF-alpha was measured using
cytotoxicity against WEHI-164 cells as an index. The virus titer
and TNF-alpha production were significantly higher in the
culture supernatant of macrophages inoculated with a mixture of
FIPVand MAb 6-4-2, than in that of macrophages cultured with
medium alone, virus alone, and MAb 6-4-2 alone (Fig. 1A). The
intracellular FCoV gene and TNF-alpha mRNA expressionphages. SPF cat-derived macrophages (2×106 cells) were cultured with medium
and culture supernatant were collected. The virus titer in the culture supernatant
ing cytotoxicity against WEHI-164 cells as an index (A, right). In addition, the
T–PCR. The FCoV N gene and TNF-alpha mRNAwere quantitatively analyzed
DH. n=5, **p<0.01. N.D.: not detected.
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with a mixture of FIPV and MAb 6-4-2 (Fig. 1B), showing that
TNF-alpha production was increased with an increase in virus
production in macrophages in which ADE was induced.
Relationship between TNF-alpha production and virus
replication in FIPV-infected macrophages
To investigate whether TNF-alpha in FIPV-infected macro-
phages is related to viral replication, the following experiment
was performed. Feline alveolar macrophages were inoculated
with a mixture of FIPV inactivated at 56 °C for 30 min and MAb
6-4-2, and TNF-alpha production was investigated with time.
When macrophages were inoculated with a mixture of non-heat-
inactivated (live) FIPV and MAb 6-4-2, the intracellular TNF-
alpha mRNA expression level (Fig. 2A) and the culture
supernatant TNF-alpha level (Fig. 2B) increased with time.
However, in macrophages inoculated with a mixture of heat-
inactivated FIPVand MAb 6-4-2, both levels were significantly
lower than those in cells inoculated with a mixture of live FIPV
and MAb on days 2 and 3 of culture (Figs. 2A and B).Fig. 2. TNF-alpha production in FIPV-infected macrophages depends on viral
replication. SPF cat-derived macrophages (2×106 cells) were inoculated with a
mixture of heat-inactivated FIPVand α-FIPV S MAb (white circle) or a mixture
of live FIPV and α-FIPV S MAb (black circle), and the cells and culture super-
natant were collected daily for 3 days. (A) TNF-alpha mRNA in the cells was
detected by RT–PCR. TNF-alpha mRNAwas quantitatively analyzed in terms of
the relative density value to the mRNA for the housekeeping gene GAPDH. (B)
TNF-alpha production in the culture supernatant was measured using
cytotoxicity against WEHI-164 cells as an index. n=5, **p<0.01.Feline peripheral blood mononuclear cells (PBMC)
apoptosis-inducing activity of FIPV-infected macrophage
culture supernatant
Whether the culture supernatant of FIPV-infected macro-
phages induces apoptosis of SPF cat-derived PBMC was inves-
tigated. SPF cat-derived macrophages (2×106 cells) were
culture with medium alone, FIPV alone, a mixture of FIPV and
MAb 6-4-2, and MAb 6-4-2 alone, and the culture supernatants
were collected after 3 days. The PBMC of SPF cats (2×106
cells) were cultured at 37 °C for 4 h in the presence of each
culture supernatant, and apoptotic cells were detected by
TUNEL. As shown in Fig. 3, the feline PBMC apoptosis
induction rate was significantly higher in the presence of the
culture supernatant of macrophages inoculated with a mixture of
FIPV and MAb 6-4-2 than in the other 3 groups.
FCoV N gene and TNF-alpha and fAPN mRNA expression
levels in macrophages of FIP and SPF cats
The FCoV N gene and TNF-alpha mRNA expression levels
were compared between alveolar macrophages derived from
FIP and SPF cats. The FCoV N gene and TNF-alpha mRNA
expression levels were increased in alveolar macrophages
derived from FIP cats (Figs. 4A and B). Interestingly, the
mRNA expression level of FCoV type II virus receptor, fAPN,
was also increased in FIP cat-derived alveolar macrophages
(Fig. 4C).
Relationship between fAPN mRNA expression level and FIPV
infection in cultured feline macrophages
In FIP cat-derived alveolar macrophages, the TNF-alpha and
fAPNmRNA expression levels increased with an increase in the
FCoV N gene expression level. Thus, changes in the FCoV N
gene and fAPN mRNA expression levels in FIPV-infected
alveolar macrophages were compared. When SPF cat-derived
alveolar macrophages were inoculated with FIPVand a mixture
of FIPV and MAb 6-4-2, as in Figs. 1 and 3, the intracellular
FCoV N gene expression level increased, with which the fAPN
mRNA level also increased (Fig. 5).
The presence of fAPN-inducing factor in FIPV-infected
macrophage culture supernatant
The presence of a fAPN-inducing factor in the FIPV-infected
macrophage culture supernatant was investigated. The culture
supernatant of macrophages inoculated with a mixture of FIPV
and MAb 6-4-2 for 3 days was heated at 56 °C for 30 min to
inactivate viruses. The supernatant was then added to medium at
10%, and used for culturing fresh alveolar macrophages. The
intracellular fAPN mRNA and cell surface fAPN expression
levels were measured over time. As the control, alveolar macro-
phages were cultured with heat-inactivated culture supernatant
of uninfected macrophages. Both the intracellular fAPN mRNA
and cell surface fAPN expression levels were significantly
increased in cells inoculated with the mixture of FIPVand MAb
Fig. 3. PBMC apoptosis-inducing activity of FIV-infected macrophage culture
supernatant. SPF cat-derived macrophages (2×106 cells) were cultured with
medium alone, FIPV, FIPV+α-FIPV S MAb, and α-FIPV MAb alone, and the
culture supernatants were collected after 3 days. The PBMC of SPF cats (2×106)
were cultured at 37 °C for 4 h in the presence of each culture supernatant, and
apoptotic cells were detected by TUNEL. n=6, **p<0.01.
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supernatant (Figs. 6A and B).
Changes in the fAPN expression level in macrophages treated
with recombinant feline TNF-alpha
The fAPN expression level increased with an increase in
TNF-alpha production in alveolar macrophages derived from
FIP cats and macrophages inoculated with FIPV in vitro. To
investigate the relationship between TNF-alpha and fAPN ex-
pression, cultured macrophages were treated with recombinant
feline TNF-alpha, and changes in the fAPN expression level
were investigated. Alveolar macrophages were cultured with
medium containing recombinant feline TNF-alpha for 5 days,
and the intracellular fAPN mRNA and cell surface fAPN ex-
pression levels were measured over time. When TNF-alpha was
added to the culture at 1 and 10 ng/ml, the fAPN mRNA ex-
pression level was significantly increased on days 3 and 5 in both
treatment groups compared to the control group (TNF-alpha:
0 ng/ml) (Fig. 7A). The surface fAPN expression level was also
significantly increased on day 5 in cells cultured with 10 ng/ml
TNF-alpha (Fig. 7B).Fig. 4. FCoV N gene, TNF-alpha, and fAPN mRNA expression levels in macrophage
FIP and SPF cats, and the FCoV N gene (A), TNF-alpha mRNA (B), and fAPN mR
fAPN mRNA were quantitatively analyzed in terms of the relative density value toFIPV replication in recombinant feline TNF-alpha-treated
macrophages
To investigate the influence of macrophages cultured in the
presence of recombinant feline TNF-alpha on FIPV infection,
whether an increase in fAPN expression in macrophages in-
creased the FIPV infectivity of macrophages was investigated.
Macrophages cultured with medium containing TNF-alpha for
5 days were inoculated with FIPV strain 79-1146, and the virus
titer in the culture supernatant was measured over time. FIPV
production was significantly increased in macrophages cultured
with TNF-alpha and inoculated with FIPV, compared to cells
without TNF-alpha (Fig. 8), and the FIPV titer increased in a
manner dependent on the TNF-alpha concentration in the cul-
ture medium.
Discussion
When anti-FCoV antibody-positive cats are inoculated with
FIPV, FIP develops earlier and symptoms are severer compared
to antibody-negative cats (Pedersen and Boyle, 1980). This
ADE-induced aggravation of the pathology in FIP cats has been
interpreted that binding of FIPV with antibodies elevates the
macrophage infection efficiency, increasing virus production.
We demonstrated that TNF-alpha production was elevated with
an increase in virus production in macrophages inoculated with a
mixture of antibody and FIPV (ADE-induced FIPV-infected
macrophages). When macrophages were inoculated with heat-
inactivated FIPV, TNF-alpha production was not increased,
suggesting that FIPV replication in macrophages is necessary to
induce TNF-alpha. TNF-alpha is a cytokine involved in the
regulation of immune function, cell proliferation, and cell dif-
ferentiation. However, overproduction of TNF-alpha is known
to have a negative influence on the body. For example, aggra-
vation of the pathology by overproduction of TNF-alpha in
inflammatory diseases, such as rheumatoid arthritis and
Crohn's disease, and viral infections, such as dengue and
Ebola virus infections, has been reported (Atrasheuskaya et al.,s of FIP and SPF cats. Alveolar macrophages (2×106 cells) were collected from
NA (C) were detected by RT–PCR. The FCoV N gene, TNF-alpha mRNA, and
the mRNA for the housekeeping gene GAPDH. n=7, N.D.: not detected.
Fig. 5. Relationship between fAPN mRNA expression and FIPV infection in cultured feline macrophages. SPF cat-derived macrophages (2×106 cells) were cultured
with medium alone, FIPV, FIPV+α-FIPV S MAb, and α-FIPV MAb alone. The cells were collected after 3 days, and the FCoV N gene and fAPN mRNA were
detected by RT–PCR. FCoV N gene and fAPN mRNAwere quantitatively analyzed in terms of the relative density value to the mRNA for the housekeeping gene
GAPDH. n=5, **p<0.01. N.D.: not detected.
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We detected an increased feline PBMC apoptosis-inducing
activity in the culture supernatant of ADE-induced FIPV-infec-
ted macrophages. We have recently reported that the culture
supernatant of peritoneal exudate cells (adherent cells with
macrophage morphology) from FIP cats had a feline PBMC
apoptosis-inducing activity (Takano et al., 2007). We also
reported the possibility that this apoptosis induction was due to
TNF-alpha contained in the culture supernatant. In this study, the
TNF-alpha content in the culture supernatant of ADE-induced
FIPV-infected macrophages was higher than that in the culture
supernatant of macrophages inoculated with FIPV alone, sup-
porting that TNF-alpha is important as an apoptosis-inducing
factor, as we previously reported.Fig. 6. fAPN expression in feline macrophages treated with FIPV-infected macro
inoculated with a mixture of FIPVand α-FIPV SMAb. The culture supernatant was co
derived macrophages (2×106 cells) were cultured with medium containing 10% ina
culture, and the intracellular fAPN mRNA (A) and cell surface fAPN (B) expression
relative density value to the mRNA for the housekeeping gene GAPDH. White circle
with culture supernatant of macrophages inoculated with a mixture of FIPV and α-
(control) macrophages.We also initially discovered that the mRNA expression level
of the FIPV virus receptor, fAPN, was increased in FIP cat-
derived macrophages. Furthermore, we revealed that fAPN
expression was increased in macrophages infected with FIPV in
vitro, particularly in ADE-induced FIPV-infected macrophages,
and confirmed the presence of a factor inducing fAPN expres-
sion in the culture supernatant of these macrophages. Heating
this culture supernatant at 56 °C for 30 min did not inactivate the
fAPN expression-inducing activity, suggesting that this factor is
heat-resistant. Since the TNF-alpha level was increased in the
FIPV-infected macrophage culture supernatant, as described
above, and TNF-alpha is heat-resistant, we predicted that this
fAPN-inducing factor is TNF-alpha. To verify this hypothesis,
we treated macrophages with recombinant feline TNF-alpha,
and investigated its influence on fAPN expression. As we ex-phage culture supernatant. SPF cat-derived macrophages (2×106 cells) were
llected after 3 days, and heated at 56 °C for 30 min to inactivate viruses. SPF cat-
ctivated culture supernatant. The cells were collected on days 0, 1, 3, and 5 of
levels were measured. fAPN mRNAwas quantitatively analyzed in terms of the
: Treatment with control macrophage culture supernatant, black circle: treatment
FIPV S MAb. n=5, **p<0.01 vs. treatment with culture supernatant of intact
Fig. 7. Changes in fAPN expression level in macrophages treated with recombinant feline TNF-alpha. SPF cat-derived macrophages (2×106 cells) were cultured with
medium containing 1 and 10 ng/ml recombinant feline TNF-alpha. The cells were collected on days 0, 1, 3, and 5 of culture, and the intracellular fAPNmRNA (A) and
cell surface fAPN (B) expression levels were measured. fAPN mRNA was quantitatively analyzed in terms of the relative density value to the mRNA for the
housekeeping gene GAPDH. n=5, **p<0.01 vs. TNF-alpha 0 ng/ml.
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crophages. We speculated that TNF-alpha may have been
produced as FIPV replicated, and autocrinally or paracrinally
acted onmacrophages and promoted fAPN expression. To verify
this concept, it is necessary to examine whether anti-feline TNF-
alpha antibody can inhibit the ability of the FIPV-infected ma-
crophage culture supernatant to induce fAPN in macrophages.
We also revealed that infection of recombinant feline TNF-
alpha-treated macrophages with FIPV increased FIPV produc-
tion. TNF-alpha is known to affect other viral infections. It has
been reported that TNF-alpha makes vascular endothelial cell
invasion by viruses easier in Ebola virus infection (Yonezawa et
al., 2005). In rhinovirus infection, when cells were infected after
treatment with TNF-alpha, the infection efficiency was
increased compared to that in untreated cells (Subauste et al.,
1995), and this was considered to be due to an increase in the
expression level of the rhinovirus receptor, ICAM-1 (Shafrenet al., 1999). In FIPV infection, TNF-alpha may similarly act on
macrophages and increase the fAPN expression level, increasing
FIPV sensitivity.
We initially demonstrated that TNF-alpha production in-
creased with viral replication in FIPV-infected macrophages,
and this TNF-alpha acted on macrophages and promoted fAPN
expression. We also confirmed that FIPV infectivity was ele-
vated as fAPN expression increased in macrophages. TNF-alpha
production was significantly increased in ADE-induced FIPV-
infected macrophages compared to macrophages infected with
FIPV alone. It was suggested that when humoral immunity is
induced in FIPV-infected cats, ADE induces viral replication in
macrophages and overproduction of TNF-alpha, resulting in: 1)
lymphocyte apoptosis induction, and 2) advanced FIP onset due
to the virus sensitivity being upregulated by the increased virus
receptor (fAPN) expression in macrophages. Based on the fact
that weakly pathogenic FECV is less likely to infect macro-
Fig. 8. FIPV replication in macrophages treated with recombinant feline TNF-
alpha. SPF cat-derived macrophages (2×106 cells) were cultured with medium
containing 1 and 10 ng/ml recombinant feline TNF-alpha for 5 days. The cells
were then inoculated with FIPV, and the culture supernatants were collected
every 12 h for 2 days. The virus titers in the supernatants were measured by
plaque assay. White bar: without TNF-alpha, gray bar: 1 ng/ml TNF-alpha was
added, black bar: 10 ng/ml TNF-alpha was added. n=4, **p<0.01.
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macrophage tropism of the virus was involved in the develop-
ment of FIP due to infection with FCoV (FIPV). Investigation of
a balance with induction of cellular immunity is expected.
Materials and methods
Experimental animals
Seven 6- to 8-month-old anti-FCoV antibody-negative SPF
cats were inoculated with 104 TCID50/ml of FIPV strain 79-
1146. These seven cats developed FIP symptoms, such as fever,
weight loss, peritoneal or pleural effusion, dyspnea, ocular
lesions, and neural symptoms, and were used as FIP cats. Seven
6- to 8-month-old SPF cats as controls were also used in this
study.
Cell cultures
Felis catus whole fetus-4 (fcwf-4) cells were grown in
Eagle's minimum essential medium containing 50% L-15 me-
dium, 5% fetal calf serum (FCS), and antibiotics.
Feline PBMC, alveolar macrophages, andWEHI-164 murine
sarcoma cells were maintained in RPMI 1640 growth medium
supplemented with 10% FCS, antibiotics, 50 μM 2-mercaptoe-
thanol, and 2 μg/ml of polybrene. WEHI-164 murine sarcoma
cells (ATCC CRL1751) were obtained from the American Type
Culture Collection.
Monoclonal antibodies (MAbs)
MAb 6-4-2 (IgG2a) used in the present study recognizes S
protein of the virus, as demonstrated by immunoblotting. It has
been reported that MAb 6-4-2 exhibits a neutralizing activity in
fcwf-4 and CrFK cells, but exhibits an enhancing activity infeline macrophages depending on the reaction conditions
(Hohdatsu et al., 1993). For MAb recognizing fAPN, R-G-4
(IgG1) prepared by our laboratory was used (Hohdatsu et al.,
1998).
Recovery of alveolar macrophages
Feline alveolar macrophages were obtained by broncho-al-
veolar lavage with HBSS from SPF cats and FIP cats, as pre-
viously described by Hohdatsu et al. (1991b).
Inoculation of feline alveolar macrophages with FIPV
Viral suspension (FIPV strain 79-1146, 2×103 TCID50/
0.1 ml) and MAb 6-4-2 solution were mixed at an equivalent
volume ratio and reacted at 4 °C for 1 h, and 0.1 ml of this
reaction solution was used to inoculate feline alveolar
macrophages (2×106 cells) cultured in each well of 24-well
multi-plates. As the control, medium alone, virus suspension
alone, and MAb 6-4-2 solution alone were added to feline
alveolar macrophages. After virus adsorption at 37 °C for 1 h,
the cells were washed with HBSS and 1 ml of growth medium.
The cells and culture supernatant were collected every 24 h
thereafter. The cells were used for measurement of the FCoV N
gene, TNF-alpha mRNA, and fAPN mRNA, and the culture
supernatant was used for the quantitative analysis of the virus
titer and cytotoxic activity against TNF-alpha using WEHI-164
cells.
Plaque assay
Confluent fcwf-4 cell monolayers in 24-well multi-plates
were inoculated with 100 μl of the sample dilutions. After virus
adsorption at 37 °C the cells were washedwith HBSS and 1ml of
growth medium containing 1.5% carboxymethyl cellulose was
added to each well. The cultures were incubated at 37 °C for
2 days, fixed in 10% buffered formalin, and stained with 1%
crystal violet.
RNA isolation and cDNA preparation
RNA isolation and cDNA preparation were performed by the
method of Takano et al. (2007).
Determination of levels of feline GAPDH, TNF-alpha,
fAPN mRNA, and FCoV N gene expression
cDNA was amplified by PCR using specific primers for
feline GAPDH, TNF-alpha, fAPN, and FCoV N genes. The
primer sequences are shown in Table 1.
PCR was performed by the method of Takano et al. (2007).
Band density was quantified under appropriate UVexposure
by video densitometry using Scion Image software (Scion
Corporation, USA).
To quantify TNF-alpha, fAPN mRNA and the FCoV N gene
were quantitatively analyzed in terms of the relative density
value to the mRNA for the housekeeping gene GAPDH.
Table 1
Sequences of PCR primers for feline GAPDH, TNF-alpha, fAPN, and FCoV N
Orientation Nucleotide sequence Location Length (bp) Reference
GAPDH Forward 5′-AATTCCACGGCACAGTCAAGG-3′ 158–178 97 Avery and Hoover (2004)
Reverse 5′-CATTTGATGTTGGCGGGATC-3′ 235–254
TNF-alpha Forward 5′-TGGCCTGCAACTAATCAACC-3′ 195–214 251 Avery and Hoover (2004)
Reverse 5′-GTGTGGAAGGACATCCTTGG-3′ 426–445
fAPN Forward 5′-AGGCTACAGATGCTCGGAAA-3′ 614–633 249 GenBank Accession No. U96104
Reverse 5′-ACTGGGAGCTCTTGTCTCCA-3′ 863–882
FCoV N Forward 5′-CAACTGGGGAGATGAACCTT-3′ 876–895 788 GenBank Accession No. X56496
Reverse 5′-GGTAGCATTTGGCAGCGTTA-3′ 1644–1663
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Cytotoxic activity against TNF-alpha were detected by the
method of Takano et al. (2007) using WEHI-164 cells.
Separation of PBMC
Heparinized blood (10 ml) was 2-fold diluted with phosphate-
buffered saline (PBS), and subjected to Ficoll–Hypaque density
gradient centrifugation at 1700 rpm for 20 min. The PBMC layer
was collected, washed twice with PBS, and resuspended with
growth medium at 2×106 cells/ml.
Apoptosis-inducing activities of culture supernatant of alveolar
macrophage on PBMC
PBMC (2×106 cells) were cultured for 4 h in the presence of
culture supernatant of alveolar macrophage (final concentration
of 1:2), and were examined for their apoptosis-inducing acti-
vities. For alveolar macrophage culture supernatants, macro-
phages (2×106 cells) were inoculated with FIPV alone, anti-
FIPV (α-FIPV) SMAb alone, and a mixture of FIPV+α-FIPV S
MAb, and the supernatants were collected after 72 h.
Apoptosis induction was detected by the TUNEL method
using flow cytometric analysis.
Detection of apoptosis by TUNEL
The apoptotic cells was detected by TUNEL according to the
method of Takano et al. (2007).
Measurement of fAPN expression level in feline alveolar
macrophages cultured with recombinant feline TNF-alpha
Feline alveolar macrophages (2×106 cells) were cultured in
medium containing recombinant feline TNF-alpha (R&D Sys-
tems, USA) at 1 and 10 ng/ml. The cells were collected after
culturing for 1, 3, and 5 days, and fAPNmRNA expression level
and macrophage surface fAPN expression level were measured.
Measurement of macrophage surface fAPN expression level by
flow cytometric analysis
A total of 2×106 cells were incubated with α-fAPN MAb at
4 °C for 50 min. The cells were washed twice in PBS containing0.1% sodium azide and incubated with FITC-conjugated Fab of
goat anti-mouse IgG antibody (MP Biomedicals, USA). The
cells were again washed twice, and the fluorescence intensity
was measured using a FACS 440 cell sorter. The value cal-
culated by subtracting the positive rate on reaction with control
MAb, belonging to the same subclass as α-fAPN MAb, from
the positive rate on reaction with α-fAPNMAb was regarded as
the positive rate of fAPN.
FIPV replication in feline alveolar macrophages cultured with
recombinant feline TNF-alpha
Feline alveolar macrophages (2×106 cells) were cultured in
medium containing recombinant feline TNF-alpha (R&D Sys-
tems, USA) at 1 and 10 ng/ml for 5 days. The cells were then
inoculated with FIPV strain 79-1146 (103 TCID50/0.1 ml). The
culture supernatant was collected every 12 h, and the virus
infection titer was measured by plaque assay.
Statistical analysis
Data were analyzed by Student's t test. P values <0.05 were
considered to indicate a significant difference between com-
pared groups.
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